Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Enrolling By Invitation NCT07911306

Investigation of the Treatment of Patients With Mitochondrial Defects by Assisted Reproductive Technology

Conditions: Pearson Syndrome, Mitochondria DNA Deletion

Sex: Female
Ages: 20 Years – 45 Years
Healthy volunteers: Yes
Phase: NA
Enrollment: 6
Sponsor: Taipei Fertility Center

Location: Taipei Fertility Center Taipei

Summary

Mitochondria are important organelles that generate energy (ATP) in human and mammalian cells. Currently, there are more than 50 kinds of diseases known to be related to mitochondrial defects in Taiwan. The incidence of mitochondrial diseases is very rare, about 1/5,000 to 1/10,000. The abundancy of mitochondria riches to 100,000 DNA copies in one oocyte, and the threshold of DNA mutation rate to cause pathogenicity is usually greater than 70%. Since mitochondria are inherited maternally, the pathogenic mitochondrial DNA in oocytes could be removed by modern artificial reproductive technology (ART). By treating with mitochondria replacement therapy (MRT), here we use the spindle transfer, following artificial insemination, the ooplasm from healthy donor oocytes could be transferred into the oocytes of patients to remove defected mitochondria, therefore creating the opportunity to produce healthy offspring. Therefore, in order to further detect the carrying rate of mutated mitochondrial genes in patients with mitochondrial defects after MRT, we aim to detect the mitochondria mutation in germ cells of patients in order to improve the specificity and operation procedures of this therapy.

Eligibility Criteria

Inclusion Criteria: * Women with mitochondria defects or mutation as oocyte recipient. * Women with history of miscarriages or deliveries of progenies carried mitochondria defects or mutations as oocyte recipient. * Healthy oocyte donor: Healthy women aged 20-40 y/o as oocyte donor. Exclusion Criteria: * History of cervical cancer * Carriers for other diseases that might affect the examination of PGS * Pregnant women * HIV infections

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07911306). StuddyBuddy aggregates publicly available trial information.